OASIS trials: establishing effective doses Phase 2 OASIS 1 findings: Tested multiple dose levels: 0.3mg, 0.6mg, 1.2mg, 2.4mg, 4.5mg weekly Duration: 26 weeks Primary endpoint: Weight loss at each dose Dose-response results: 0.3mg weekly: ~4% body weight loss 0.6mg weekly: ~6% body weight loss 1.2mg weekly: ~8% body weight loss 2.4mg weekly: ~10% body weight loss 4.5mg weekly: ~12% body weight loss Key insight: Clear dose-response relationship
Ensure youre well-hydrated
Figure 32: Head of the Gila monster ( Heloderma suspectum ), credit: Jeff Servoss, Wikipedia
Nanomaterials are expected to dominate the worldwide market in packaging, electronics, aerospace, energy, and autos
Still, an early course of antibiotics does not eliminate the risk of chronic Lyme for those people who remain sick after standard treatment, says physician Elizabeth Maloney, MD, president of Partnership for Tick-Borne Diseases Education
2018;45:S534